Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
9.29M
-
Shares change
-
+21K
-
Total reported value, excl. options
-
$18.1M
-
Value change
-
+$41K
-
Number of buys
-
2
-
Price
-
$1.95
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2013
32 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2013.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.29M shares
of 123M outstanding shares and own 7.54% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (3.25M shares), ORBIMED ADVISORS LLC (1.9M shares), VANGUARD GROUP INC (1.43M shares), Opaleye Management Inc. (1.35M shares), Ghost Tree Capital, LLC (175K shares), GEODE CAPITAL MANAGEMENT, LLC (165K shares), ZACKS INVESTMENT MANAGEMENT (155K shares), AQR CAPITAL MANAGEMENT LLC (150K shares), TANAKA CAPITAL MANAGEMENT INC (120K shares), and Bank of New York Mellon Corp (101K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.